Abstract
The steroid hormone, thyroid hormone, retinoic acid, and vitamin D receptors are members of a family of ligand-activated transcription factors (Mangelsdorf et al. 1995). These nuclear hormone receptors contain two signature domains, a central double zinc finger DNA-binding domain (DBD) and a C-terminal ligand-binding domain (LBD) (Fig. 1). Sequence homology within these domains has allowed investigators to clone many additional members of the gene family. It is now known that there are a total of 48 nuclear receptors within the human genome (Maglich et al. 2001). The majority of these transcription factors are designated orphan receptors since they do not bind to the classical endocrine hormones. Characterization of the biological function of the orphan nuclear receptors has become an important endeavor of biomedical research, since each of them has the potential to be the regulator of a new hormone signaling pathway (Giguere 1999).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beato M, Herrlich P, Schuetz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83: 851–857
Brown PI, Smith-Oliver TA, Charifson PS, Tomkinson NCO, Fivush AM, Sternbach DD, Wade LE, Orband-Miller L, Parks DJ, Blanchard SG, Kliewer SA, Lehmann JM, Willson TM (1997) Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library. Chem Biol 4: 909–918
Brown PJ, Stuart LW, Hurley KP, Lewis MC, Winegar DA, Wilson JG, Wilkison WO, Ittoop OR, Willson TM (2001) Identification of a subtype selective human PPARa agonist through parallel-array synthesis. Bioorg Med Chem Lett 1227–1227
Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ (2001) Nuclear receptors and lipid physiology: opening the X-files. Science 294: 1866–1870
Collins JL, Fivush AM, Watson MA, Galardi CM, Lewis MC, Moore LB, Parks DJ, Plunket KD, Tippin TK, Morgan DG, Beaudet EJ, Whitney KD, Wilson JG, Kliewer SA, Willson TM (2002) Identification of a non-steroidal LXR agonist through parallel array synthesis of tertiary amines. J Med Chem 45: 1963–1966
Gampe RT Jr, Montana VG, Lambert MH, Miller AB, Bledsoe RK, Milburn MV, Kliewer SA, Willson TM, Xu HE (2000) Asymmetry in the PPARy/RXRa crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol Cell 5: 545–555
Giguere V (1999) Orphan nuclear receptors: from gene to function. Endocr Rev 20: 689–725
Herbst RS, Nielsch U, Sladek F, Lai E, Babiss LE, Darnell JE, Jr. (1991) Differential regulation of hepatocyte-enriched transcription factors explains changes in albumin and transthyretin gene expression among hepatoma cells. New Biol 3: 289–96
Hermanson O, Glass CK, Rosenfeld MG (2002) Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13: 55–60
Jones SA, Moore LB, Shenk JL, Wisely GB, Hamilton GA, McKee DD, Tomkinson NCO, LeCluyse EL, Lambert MH, Willson TM, Kliewer SA, Moore JT (2000) The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol Endocrinol 14: 27–39
Kliewer SA, Lehmann JM, Willson TM (1999) Orphan nuclear receptors: shifting endocrinology into reverse. Science 284: 757–760
Lausen J, Thomas H, Lemm I, Bulman M, Borgschulze M, Lingott A, Hattersley AT, Ryffel GU (2000) Naturally occurring mutations in the human HNF4a gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res 28: 430–437
Maglich JM, Sluder A, Guan X, Shi Y, McKee DD, Carrick K, Kamdar K, Willson TM, Moore JT (2001) Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol 2:research0029. 1–0029. 7
Maloney PR, Parks DJ, Haffner CD, Fivush AM, Chandra G, Plunket KD, Creech KL, Moore LB, Wilson JG, Lewis MC, Jones SA, Willson TM (2000) Identification of a chemical tool for the orphan nuclear receptor FXR. J Med Chem 43: 2971–2974
Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schuetz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM (1995) The nuclear receptor superfamily: the second decade. Cell 83: 835–839
Nolte RT, Wisely GB, Westin S, Cobb JE, Lambert MH, Kurokawa R, Rosenfeld MG, Willson TM, Glass CK, Milburn MV (1998) Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-y. Nature 395: 137–143
Oliver WR, Shenk JL, Snaith MR, Russell CS, Plunket KD, Bodkin NL, Lewis MC, Winegar DA, Sznaidman ML, Lambert MH, Xu HE, Sternbach DD, Kliewer SA, Hansen BC, Willson TM (2001) A selective peroxisome proliferator-activated receptor S agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98: 5306–5311
Repa JJ, Turley SD, Lobaccaro JMA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524–1529
Ruse MD, Pivalsky ML, Sladek FM (2002) Competitive cofactor recruitment by orphan receptor hepatocyte nuclear factor 4a1: modulation by the F domain. Mol Cell Biol 22: 1626–1638
Ryffel GU (2001) Mutations in the human genes encoding the transcription factors of the hepatocyte nuclear factor (HNF)1 and HNF4 families: functional and pathological consequences. J Mol Endocrinol 27: 11–29
Schrem H, Klempnauer J, Borlak J (2002) Liver-enriched transcription factors in liver function and development. Part I: the hepatocyte nuclear factor network and liver-specific gene expression. Pharmacol Rev 54: 129–158
Sorbera LA, Leeson PA, Martin L, Castaner J (2001) Farglitazar. Drugs of the Future 26: 354–363
Tzameli I, Pissios P, Schuetz EG, Moore DD (2000) The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol Cell Biol 20: 2951–2958
Weatherman RV, Fletterick RJ, Scanlan TS (1999) Nuclear-receptor ligands and ligand-binding domains Annu Rev Biochem 68: 559–581
Willson TM, Kliewer SA (2002) PXR, CAR and drug metabolism. Nat Rev Drug Discov 1: 259–266
Willson TM, Moore JT (2002) Genomics v orphan nuclear receptors — a halftime report. Mol Endocrinol 16: 1135–1144
Willson TM, Brown PJ, Sternbach DD, Henke BR (2000) The PPARs: from orphan receptors to drug discovery. J Med Chem 43: 527–550
Willson TM, Lambert MH, Kliewer SA (2001) Peroxisome proliferator-acti- vated receptor y and metabolic disease. Annu Rev Biochem 70: 341–367
Wisely GB, Miller AB, Davis RG, Thornquest AD Jr, Johnson R, Spitzer T, Sefler A, Shearer B, Moore JT, Miller AB, Willson TM, Williams SP (2002) Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 10: 1225–1234
Wurtz J-M, Bourguet W, Renaud J-P, Vivat V, Chambon P, Moras D, Gronemeyer H (1996) A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol 3: 87–94
Xu HE, Lambert MH, Montana VG, Parks DJ, Blanchard SG, Brown PJ, Sternbach DD, Lehmann JM, Wisely GB, Willson TM, Kliewer SA, Milburn MV (1999) Molecular recognition of fatty acids by peroxisome proliferator-activated receptors. Mol Cell 3: 397–403
Xu HE, Lambert MH, Montana VG, Plunket KD, Moore LB, Collins JL, Op-linger JA, Kliewer SA, Gampe RT, Jr., McKee DD, Moore JT, Willson TM (2001) Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 98: 13919–13924
Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Willson TM, Stimmel JB (2002) Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARa. Nature 415: 813–816
Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413: 131–138
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Willson, T. (2003). Chemical Genomics of Orphan Nuclear Receptors. In: Waldmann, H., Koppitz, M. (eds) Small Molecule — Protein Interactions. Ernst Schering Research Foundation Workshop, vol 42. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-05314-0_4
Download citation
DOI: https://doi.org/10.1007/978-3-662-05314-0_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-05316-4
Online ISBN: 978-3-662-05314-0
eBook Packages: Springer Book Archive